CAH vs CE · P/E 35, rev $222.58B vs rev $10.28B
Cardinal Health Inc (CAH) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CE currently screens at market cap $5.92B.
Not investment advice. Open the CAH and CE stock pages for the full models.
Not investment advice.